If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...

AI adoption in the corporate world is not a sprint—it’s a strategic journey where early experimentation gives way to ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The department’s chief data and artificial intelligence office and members of the Data & AI Board will oversee the new center.

The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing ...

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.